Immunogenicity of Current IBD Biologics With Drs. Edward Loftus and Marla Dubinsky
In this podcast, expert clinicians compare the immunogenicity of available biologic therapies and explore options for managing patients who develop an...
MedEdTalks - Gastroenterology
Share:
Listens: 4
About
MedEdTalks Gastroenterology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on gastroenterology topics, such as ulcerative colitis (UC) and Crohn’s disease and includes interviews with Dr. Peter Higgins from the University of Michigan, Dr. David Rubin from the University of Chicago and Dr. William Sandborn from the University of California, San Diego.
Extraintestinal Manifestations of IBD With Drs. Edward Loftus and Miguel Regueiro
In this podcast, expert clinicians review the variety of extraintestinal manifestations seen in patients with IBD, discussing strategies for assessmen...
Biologics for IBD – Monotherapy Versus Combination Approaches With Drs. Edward Loftus and Marla Dubinsky
In this podcast, experts review appropriate applications of monotherapy and combination therapy and how to position particular therapies based on dise...
New Insights on Treat to Target in Moderate to Severe IBD With Drs. Edward Loftus and Miguel Regueiro
In this podcast, expert clinicians will discuss the shift from symptom-based management to a treat-to-target paradigm, detailing important treatment a...
Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-IL-23 and JAK inhibitors, that are in late-stage deve...
Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in l...
Mechanisms of Action of New Classes of Agents for Moderate to Severe Crohn’s Disease with Drs. William J. Sandborn and Bruce E. Sands
In this podcast, expert clinicians will discuss emerging therapies with unique mechanisms of action that can improve the treatment of moderate to seve...
Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 Inhibitors
Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 InhibitorsInflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s...
Investigational Agents in Ulcerative Colitis: JAK Inhibitors and S1P Receptor Modulators
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Al...
Investigational Agents in Ulcerative Colitis: Anti-Integrins
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Al...